NCT05404945 · Interventional trial
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Overall registry status Active not recruiting
Phase 2
Conditions Classical Hodgkin Lymphoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory